All four FDA-approved oral medications for erectile dysfunction belong to the same drug class and share a similar safety profile. None is dramatically safer than the others, but avanafil (the newest option, approved in 2012) has the edge in two key areas: fewer vision-related side effects and no recorded impact on heart rhythm. For most men, the real safety question isn’t which pill to pick but whether their overall health, especially their heart and current medications, makes any of these drugs risky.
How All Four Oral Medications Compare
The four oral ED medications, sildenafil, tadalafil, vardenafil, and avanafil, all work the same way: they relax blood vessels in the penis so blood flows in more easily during arousal. Because the mechanism is identical, the most common side effects overlap. Headache, facial flushing, and nasal congestion show up across all four. The differences come down to how selective each drug is, meaning how precisely it targets the intended enzyme without affecting similar enzymes elsewhere in the body.
Sildenafil is the most likely of the four to cause temporary visual disturbances, such as a blue-green tint to vision, because it partially affects an enzyme involved in how the retina processes light. Vardenafil carries a unique caution: it can slightly lengthen a specific interval in the heart’s electrical cycle (called the QTc interval), which matters for anyone with a heart rhythm condition or anyone taking certain antiarrhythmic medications. Tadalafil lasts much longer in the body (up to 36 hours versus 4 to 6 for the others), which is an advantage for spontaneity but means side effects like headache or muscle aches can linger longer too.
Avanafil is the most selective of the group. In clinical trials, only a single patient across all study doses reported any change in color vision. No cases of heart rhythm changes appeared during preapproval testing. Headache remained the most common side effect, occurring in roughly 5 to 11 percent of patients depending on the dose, which is in the same ballpark as the other drugs. So avanafil’s safety advantage is real but modest: it’s not a different class of medication, just a more refined version of the same approach.
Cardiovascular Safety
Heart health is the biggest safety concern with ED medications, and the picture is more reassuring than many people expect. A large Swedish study tracked over 43,000 men who had previously suffered a heart attack. Those who used ED medication afterward had a lower rate of major cardiac events (hospitalizations for heart attack, heart failure, or procedures to reopen blocked arteries) compared to men who did not use ED medication. The rate was roughly 2.7 events per 100 person-years in the ED medication group versus 7.4 in the untreated group, and after adjusting for other health factors, the treated group still had about a 21 percent lower risk.
This doesn’t mean ED pills protect the heart. Men healthy enough to be prescribed the medication in the first place are a healthier group overall. But the data firmly counter the fear that these drugs are heart-dangerous. The one absolute rule: ED medications must never be combined with nitrate drugs (commonly prescribed for chest pain), because the combination can cause a sudden, dangerous drop in blood pressure. This is a class-wide restriction that applies equally to all four medications.
Rare but Serious Side Effects
Two rare conditions get mentioned in the prescribing information for all oral ED drugs: a specific type of vision loss affecting one eye (non-arteritic anterior ischemic optic neuropathy, or NAION) and sudden hearing loss. Both are extremely uncommon. A post-marketing surveillance study found the rate of NAION among ED drug users was about 2.8 cases per 100,000 patient-years, which is actually within the baseline rate for men over 50 who aren’t taking these medications at all (estimated at 2.5 to 11.8 per 100,000). The data suggest these drugs don’t meaningfully increase the risk, though regulators keep the warning as a precaution.
Priapism, a prolonged erection lasting more than four hours, is another feared complication. In practice, it’s vanishingly rare with oral medications. A study of nearly 700 patients using oral ED drugs found zero cases of erections lasting beyond four hours. By comparison, 1.4 percent of patients using penile injections experienced at least one episode. If you’re taking pills rather than injections, priapism is not a realistic concern.
Oral Medications vs. Injections and Suppositories
When oral drugs don’t work or can’t be used, the next option is usually alprostadil, a medication delivered directly into the penis by injection or as a small urethral suppository. Because alprostadil acts locally at the tissue level rather than circulating throughout the bloodstream, it avoids systemic side effects like headache and flushing. The trade-off is a different set of risks: pain at the injection site, minor bleeding or bruising, and that higher priapism rate of about 1.4 percent.
For safety in the broadest sense, oral medications expose your whole body to a mild, well-tolerated drug, while injections concentrate a stronger effect in one area with more localized complications. Most men and their doctors consider oral pills the safer starting point, with injections reserved for situations where pills aren’t effective or appropriate.
What Actually Determines Safety for You
The safest ED drug for any individual depends less on which specific pill and more on three personal factors: what other medications you take, whether you have heart disease or blood pressure issues, and how your liver and kidneys process drugs.
Nitrate medications are the hardline contraindication for all four oral options. Alpha-blockers, used for enlarged prostate, can also interact and require dose adjustments. Men with severe liver impairment typically need lower doses or may not be candidates for certain options. And men with inherited retinal conditions should be especially cautious with sildenafil given its effect on the eye enzyme.
If you have no complicating health conditions and want the option with the cleanest side effect profile on paper, avanafil is the most selective choice. If you want the longest track record with the most real-world safety data spanning over two decades, sildenafil has that. Tadalafil’s long duration makes it the most practical for men who prefer a daily low-dose regimen rather than timing a pill before sex. All four have strong safety records, and the differences between them are small enough that convenience, cost, and how your body responds to a particular one will likely matter more than raw safety data.